TargetMol

Herbacetin

Product Code:
 
TAR-T5S1331
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T5S1331-1mg1mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5S1331-5mg5mg£142.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5S1331-1mL1 mL * 10 mM (in DMSO)£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5S1331-10mg10mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5S1331-25mg25mg£321.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5S1331-50mg50mg£446.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
1. Herbacetin induces apoptosis in HepG2 cells, by ROS and PI3K/Akt pathway. 2. Herbacetin suppresses the HGF-induced motility of human breast cancer MDA-MB-231 cells by inhibiting c-Met and Akt phosphorylation.
CAS:
527-95-7
Formula:
C15H10O7
Molecular Weight:
302.238
Pathway:
Cytoskeletal Signaling; Tyrosine Kinase/Adaptors; PI3K/Akt/mTOR signaling
Purity:
0.9951
SMILES:
Oc1ccc(cc1)-c1oc2c(O)c(O)cc(O)c2c(=O)c1O
Target:
c-Met/HGFR; Akt

References

Li L , Sapkota M , Kim S W , et al. Herbacetin inhibits inducible nitric oxide synthase via JNK and nuclear factor-?B in LPS-stimulated RAW264.7 cells[J]. European Journal of Pharmacology, 2015, 765:EJP42292.